Juliet Morgan
Principal Scientist, Sygnature Discovery
Juliet Morgan is listed as Principal Scientist, Sygnature Discovery. Juliet is scheduled to speak at SLAS 2027 International Conference & Exhibition on 30 January 2027.
Compiled from published conference agendas; not yet confirmed by Juliet. Is this you? Claim this profile.
About
Juliet Morgan, PhD Juliet Morgan is a Principal Scientist and Strategic Lead for Fragment-Based Drug Discovery (FBDD) at Sygnature Discovery, with over ten years of industry experience focused on applying biophysical methods to preclinical drug discovery. As a project leader, she has directed multidisciplinary teams across programmes from hit identification through to hit-to-lead development, designing and implementing screening cascades to support progression and decision-making.
Upcoming
SLAS 2027 International Conference & Exhibition 30 January 2027 – 3 February 2027
- Introduction to Pre-Clinical Drug Discovery Speaker · 30 January 2027
Spoke alongside
People who have shared a session with Juliet at events on B2DB.
- Lynette Ongeri DMPK Principal Scientist · Sygnature Discovery 1 shared session
- Sinead Knight Sygnature Discovery 1 shared session